Martin Willemink, M.D., Ph.D., is a co-founder at Segmed and serves the company as Chief Scientific Officer. He is a physician, epidemiologist, biomedical engineer, scientist, and entrepreneur. Previously, Martin directed the clinical cardiovascular imaging research at Stanford Radiology and served as CEO of Segmed. Martin published 100+ peer-reviewed papers, has been invited to present 30+ lectures at international scientific meetings, is a Fulbright laureate, and received funding from the American Heart Association, Philips Healthcare, Stanford University, and more. At Segmed, he led the company through two funding rounds, including a $10.4M Series A round, while the company grew substantially. He is designated as a Fellow of the Society of Cardiovascular Computed Tomography (SCCT) and is an active member of multiple European and North American clinical scientific societies. He is a Jr. Deputy Editor at European Radiology, the flagship journal from the European Society of Radiology. His work has amongst others been recognized with awards from the Radiological Society of North America, European Society of Radiology, Society of Thoracic Radiology, and European Society of Thoracic Imaging.